Abiomed, Inc.ABMDNASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+10.3%
5Y CAGR+18.3%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+10.3%/yr
vs +35.2%/yr prior
5Y CAGR
+18.3%/yr
Recent deceleration
Acceleration
-24.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
PeriodValueYoY Change
2022$1.03B+21.7%
2021$847.52M+0.8%
2020$840.88M+9.3%
2019$769.43M+29.6%
2018$593.75M+33.3%
2017$445.30M+35.1%
2016$329.54M+43.1%
2015$230.31M+25.4%
2014$183.64M+16.1%
2013$158.12M-